Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/24/2903300/0/en/Ultimovacs-ASA-announces-revised-terms-of-the-employee-share-option-program.html
https://www.globenewswire.com/news-release/2024/06/11/2896458/0/en/Ultimovacs-provides-update-from-Phase-I-study-in-malignant-melanoma-Continued-strong-overall-survival-in-patients-treated-with-UV1-cancer-vaccine-and-pembrolizumab.html
https://www.globenewswire.com/news-release/2024/06/01/2891817/0/en/Ultimovacs-Announces-Poster-Presentation-at-the-2024-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/05/07/2876296/0/en/Ultimovacs-ASA-Reports-First-Quarter-2024-Financial-Results-and-Provides-General-Business-Update.html
https://www.globenewswire.com/news-release/2024/04/30/2871792/0/en/Ultimovacs-ASA-Invitation-to-first-quarter-2024-results-webcast-presentation.html
https://www.globenewswire.com/news-release/2024/04/24/2868773/0/en/Ultimovacs-Announces-Poster-Presentation-at-the-2024-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/18/2865412/0/en/Ultimovacs-ASA-Annual-General-Meeting-held-on-April-18-2024.html
https://www.fiercebiotech.com/biotech/ultimovacs-lays-40-survive-wake-cancer-vaccines-phase-2-fail
https://www.globenewswire.com/news-release/2024/04/16/2864103/0/en/Ultimovacs-Implements-Operational-Adjustments-to-Support-Continuous-Advancement-of-the-UV1-Vaccine-Phase-II-Program.html
https://www.globenewswire.com/news-release/2024/04/15/2862486/0/en/Ultimovacs-ASA-Disclosure-of-voting-rights-of-Annual-General-Meeting.html